MOSTaRE Initiative – Minnesota Perinatal Quality Collaborative

Resource Category: MOSTaRE Initiative

Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorder and their Infants

Written by Yoolee Yi on March 22, 2021.

Hennepin Health Perinatal Opioid Use Disorder ECHO education series

Written by Malik_Zahid_Majeed on December 8, 2020.

Neonatal Abstinence Syndrome

Written by Malik_Zahid_Majeed on December 4, 2020.

Minnesota Department of Health Child and Family Health Division. (2019). Neonatal Abstinence Syndrome.

Written by Malik_Zahid_Majeed on December 4, 2020.

Moldenhauer, Rick. (2017). Tribal Opioid Summit “The Song Remains the Same” [PowerPoint presentation]. Tribal Opioid Summit 2017, Minnesota.

Written by Malik_Zahid_Majeed on December 4, 2020.

Pew Charitable Trusts. (2016). Medication-assisted treatment improves outcomes for patients with opioid use disorder.

Written by Malik_Zahid_Majeed on December 4, 2020.

Grossman, M.R., Lipshaw, M.J., Osborn, R.R., & Berkwitt, A.K. (2018). A novel approach to assessing infants with neonatal abstinence syndrome. Hospital Pediatrics, 8,(1), 1-6.

Written by Malik_Zahid_Majeed on December 4, 2020.

March of Dimes. (2019). Neonatal abstinence syndrome.

Written by Malik_Zahid_Majeed on December 4, 2020.

What is neonatal abstinence syndrome?

Neonatal abstinence syndrome (also called NAS) is a group of conditions caused when a baby withdraws from certain drugs he’s exposed to in the womb before birth.

McQueen, K. and Murphy-Oikonen, J. (2016). Neonatal abstinence syndrome. New England Journal of Medicine, 375, 2468-2479.

Written by Malik_Zahid_Majeed on December 4, 2020.

Opiod Overdose Prevention

Written by Malik_Zahid_Majeed on December 4, 2020.

Opioid Prevention and Statistics

1
2

info@minnesotaperinatal.org